Cipla completes ZAR 900m investment in South Africa

Cipla (BSE: CIPLA) has announced the completion of an investment of approximately ZAR 900 million in Cipla Medpro South Africa Proprietary Limited, its wholly-owned subsidiary in South Africa. The investment was made against the allotment of 40,742,417 shares. This update, dated February 18, 2025, complies with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and follows the company's intimation on February 3, 2025. The company has filed the announcement with both the BSE and the National Stock Exchange of India Limited.